Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from New China Life Insurance Co., Ltd. Class H ( (HK:1336) ) is now available.
New China Life Insurance Company Ltd. reported its unaudited first-quarter 2026 results, showing operating income of RMB 22.13 billion, down 33.7% year on year, while net profit attributable to shareholders rose 10.5% to RMB 6.50 billion. Earnings per share increased 10.1% and net operating cash flow grew 8.1%, even as total assets declined 2.4%, suggesting improved profitability and capital strength despite weaker top-line revenue.
Equity attributable to shareholders climbed 10.8% over the end of 2025, indicating enhanced balance-sheet resilience that may support future dividend capacity and regulatory capital requirements. However, the drop in operating income and a 1.15 percentage-point fall in weighted average return on equity highlight pressure on growth and returns, posing strategic questions for investors about the sustainability of earnings momentum in a challenging operating environment.
The most recent analyst rating on (HK:1336) stock is a Sell with a HK$33.00 price target. To see the full list of analyst forecasts on New China Life Insurance Co., Ltd. Class H stock, see the HK:1336 Stock Forecast page.
More about New China Life Insurance Co., Ltd. Class H
New China Life Insurance Company Ltd. is a major Chinese life insurer operating under China Accounting Standards and listed in Hong Kong. The company provides life insurance and related financial services, focusing on the mainland China market while also serving international investors through its H-share listing.
Average Trading Volume: 9,384,895
Technical Sentiment Signal: Buy
Current Market Cap: HK$199.9B
Find detailed analytics on 1336 stock on TipRanks’ Stock Analysis page.